CONCEPTUS GEARING UP FOR DOMESTIC SALES OF TRANSCERVICAL ACCESS SYSTEM
This article was originally published in The Gray Sheet
Executive Summary
CONCEPTUS GEARING UP FOR DOMESTIC SALES OF TRANSCERVICAL ACCESS SYSTEM pending clearance by FDA of 510(k) applications for the catheters and guidewires that make up the system. The company submitted 510(k)s for the intrauterine infusion devices, which can be used to help diagnose female infertility and related disorders, between May and August of 1993. Conceptus currently is "in the process of hiring a sales force to be ready for the introduction of these products at the end of August," stated Kathryn Tunstall, company president and CEO, at a May 9 session of the Alex. Brown & Sons health care seminar in Baltimore.
You may also be interested in...
Medtronic Launches Remote Live-Stream Surgery, New AI Capabilities
Medtronic will launch a new feature that allows for live streaming of surgical procedures in more than 20 countries and the addition of 14 AI-driven algorithms to enhance surgical workflow.
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.
Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups
Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.